Duchenne muscular dystrophy
- 1 July 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 31 (7) , 916
- https://doi.org/10.1212/wnl.31.7.916
Abstract
In carrying out a new study of nucleotide concentrations in dystrophic muscle, we utilized myosin as a reference base. In nine control vastus lateralis muscle samples, nucleotide concentrations were 105 211 (SEM) moles of adenosine triphosphate (ATP) and 446 ± 57 (SEM) moles of creatine phosphate (CP) per milligram of myosin. In seven Duchenne dystrophic vastus lateralis muscle samples, nucleotide concentrations were 127 ± 25 (SEMI nmoles of ATP and 462 ± 119 (SEM) moles of CP per milligram of myosin. The CPATP ratio of 3.6 2 0.367 from Duchenne muscle was not signiificantly different from normal, 4.32 ± 0.243 ((p p p <0.01). These studies suggest that ATP and CP concentrations are not decreased in Duchenne dystrophic muscle when expressed in relation to the amount of contractile protein.This publication has 7 references indexed in Scilit:
- Lack of benefit of allopurinol in duchenne dystrophyMuscle & Nerve, 1979
- X-linked recessive (Duchenne) muscular dystrophy (DMD) and purine metabolism: Effects of oral allopurinol and adenylateMetabolism, 1978
- Analysis of Living Tissue by Phosphorus-31 Magnetic ResonanceScience, 1977
- GLYCOGEN, CREATINE, AND HIGH ENERGY PHOSPHATE IN HUMAN MUSCLE DISEASE1963
- A BIOCHEMICAL STUDY OF CERTAIN SKELETAL MUSCLE CONSTITUENTS IN HUMAN PROGRESSIVE MUSCULAR DYSTROPHY*Journal of Clinical Investigation, 1959
- Distribution of high energy phosphate in normal and dystrophic muscleNeurology, 1958
- Muscle proteins in dystrophyNeurology, 1958